Latest filing published 27 Feb 2024 for Supernus Pharmaceuticals, INC., €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Tami Tillotson Martin: trading record in brief
Tami Tillotson Martin discloses dealings in Supernus Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 4 May 2012 to 23 February 2024, the count stands at 25 filings.
On the open market, the record shows 1 purchase worth €9,501 and 7 sales worth €1.1M. The net balance comes to €1.1M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 7 share grants and 10 option exercises. 2024 to date brings no purchases and 1 sale.
The record was last updated on 27 February 2024 with a share grant (€13k) in Supernus Pharmaceuticals, Inc. The last insider purchase was made public on 7 May 2012, 5,299 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tami Tillotson Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 485 shares@ US$29.060.9% of flowCommon StockSEC:0001104659-24-028269:1
- 1,250 shares0Common StockSEC:0001104659-24-028269:0
- 246 shares@ US$27.940.4% of flowCommon StockSEC:0001104659-24-027564:1
- 750 shares0Common StockSEC:0001104659-24-027564:0
- 8,000 shares@ US$27.9113.5% of flowCommon StockSEC:0001104659-24-003741:1
- 8,000 shares@ US$9.2414.3% of flowCommon StockSEC:0001104659-24-003741:0
- 8,100 shares@ US$32.0015.6% of flowCommon StockSEC:0001104659-23-097813:1
- 8,100 shares@ US$23.9937.5% of flowCommon StockSEC:0001104659-23-097813:0
- 5,135 shares@ US$31.5931.7% of flowCommon StockSEC:0001104659-23-096582:0
- 289 shares@ US$38.570.7% of flowCommon StockSEC:0001104659-23-044664:1
- 750 shares0Common StockSEC:0001104659-23-044664:0
- 750 shares0Common StockSEC:0001104659-23-025370:0
- 1,500 shares0Common StockSEC:0001104659-23-023834:0
- 5,000 shares@ US$35.9811.9% of flowCommon StockSEC:0001104659-22-093748:1
- 5,000 shares@ US$7.908.4% of flowCommon StockSEC:0001104659-22-093748:0
- 5,000 shares@ US$32.9810.6% of flowCommon StockSEC:0001104659-22-086723:1
- 5,000 shares@ US$7.908.1% of flowCommon StockSEC:0001104659-22-086723:0
- 3,125 shares@ US$12.984.8% of flowCommon StockSEC:0001104659-21-050369:0
- 3,125 shares@ US$29.9811.1% of flowCommon StockSEC:0001104659-21-050369:1
- 3,125 shares@ US$12.984.8% of flowCommon StockSEC:0001104659-21-050369:2
- 3,125 shares@ US$31.9811.9% of flowCommon StockSEC:0001104659-21-050369:3
- 37,500 shares@ US$1.60Common StockSEC:0001181431-12-064438:0
- 1,250 shares@ US$3.36Common StockSEC:0001181431-12-064438:1
- 9,375 shares@ US$2.56Common StockSEC:0001181431-12-064438:2
- 2,500 shares@ US$5.00Common StockSEC:0001179110-12-007825:0Canonical exit: 2 Aug 2012 (T+90)
25 of 25 declarations
